Sulan Lin

5PUBLICATIONS
18CO-AUTHORS
Molecular targetsPredictive and prognostic markersPopulation trends and policiesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 09, 2025
Targeting Sialylation Enhances the Therapeutic Efficacy of the Nectin-4-Targeted Antibody-Drug Conjugate Enfortumab Vedotin in Bladder Cancer.

Jilin Wu, Bisheng Cheng, Yuxuan Song

|Feb 26, 2025
Association of 5α-reductase inhibitor prescription with immunotherapy efficacy in metastatic renal cell carcinoma: a multicenter retrospective analysis.

Bisheng Cheng, Jilin Wu, Ke Chen

|Sep 30, 2024
Predicting Survival in Patients with Neuroendocrine Prostate Cancer: A SEER-Based Comprehensive Study.

Tianlong Luo, Jintao Hu, Bisheng Cheng

|Feb 07, 2023
Impact of the COVID-19 pandemic on lifestyle and mental state in patients with schizophrenia: A retrospective study.

Xiaoling Cheng, Xiaoling Huang, Xinghu Wu

|May 30, 2021
The efficacy of cytoreductive surgery for oligometastatic prostate cancer: a meta-analysis.

Bisheng Cheng, Shuchao Ye, Peiming Bai

Pageof 1

Frequent Collaborators

1 joint publications

Tianlong Luo

1 joint publications

Jintao Hu

1 joint publications

Peixian Chen

1 joint publications

Jianhan Fu